BANK OF AMERICA CORP /DE/
BankPosition in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in CPRX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$75,184,876
+$23,840,566 QoQ
Shares Held
3,036,546
+38.0% QoQ
Ownership
2.48%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. CPRX ranks #27 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $75,184,876 | 3,036,546 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $51,344,310 | 2,199,842 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $45,140,853 | 2,291,414 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $51,335,145 | 2,365,675 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,928,267 | 1,811,475 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $32,740,666 | 1,568,791 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $13,020,364 | 654,948 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,121,758 | 459,765 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,506,801 | 408,206 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,590,822 | 749,008 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,862,695 | 587,057 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,897,332 | 662,004 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $16,345,888 | 985,880 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $17,045,894 | 916,446 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $6,110,401 | 476,259 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $842,473 | 120,182 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,100,070 | 253,326 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,341,518 | 345,867 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $671,350 | 126,670 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,056,573 | 183,752 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $942,065 | 204,353 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $805,556 | 241,185 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $809,997 | 272,727 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $589,385 | 127,573 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $480,035 | 124,685 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||